Abstract
Background: These case reports document effective treatment using botulinum toxin type-A [BTX-A] in fibromyalgia syndrome [FMS] patients. Outcome measures [including pain scales, Fibromyalgia Impact Questionnaire, algometry] were recorded on 25 FMS patients undergoing repeated BTX-A injections [one to five years duration].Findings: Pain and function were improved in these patients. Muscles injected with good response included the frontalis, corrugators [for headache], levator scapulae, pectoralis minor [neck/ shoulder pain], paraspinals, piriformis and sacroiliac ligaments [low back pain]. The BTX-A worked best with biomechanical approaches incorporating postural correction and core stability strengthening.Conclusion: Our clinical experience suggests that pain in FMS patients may be effectively managed with BTX-A.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
